Offer Update

Evolution Group PLC 19 July 2002 19 July 2002 Not for release, publication or distribution in or into the United States, Canada, Japan or Australia. THE EVOLUTION GROUP PLC RECOMMENDED MERGER WITH BEESON GREGORY OFFER UPDATE Evolution announces that, acceptances of the Merger Offer for Beeson Gregory having now been received in respect of in excess of 90% of the Beeson Gregory Shares to which the Merger Offer relates, notices are today being despatched to those Beeson Gregory Shareholders who have not yet accepted the Merger Offer, pursuant to which Evolution is exercising its rights to acquire compulsorily the remaining Beeson Gregory Shares to which the Merger Offer relates in accordance with the provisions of sections 428 to 430F (inclusive) of the Act. Evolution is today also writing to the holders of options over Beeson Gregory Shares with appropriate proposals in relation to those options. As stated in previous announcements, application has already been made for cancellation of the trading of Beeson Gregory Shares on the London Stock Exchange's market for listed securities and the listing of Beeson Gregory Shares on the Official List of the UKLA and it is anticipated that such cancellations will take effect on 22 August 2002. The Merger Offer remains open for acceptance until further notice. Enquiries: The Evolution Group PLC Tel: 020 7220 4800 Alex Snow Richard Griffiths Graeme Dell Altium Capital Limited Tel: 020 7484 4040 Garry Levin Ben Bailey Sam Fuller Terms defined in the Offer Document dated 13 June 2002, have the same meaning in this press release unless the context otherwise requires. Altium Capital is acting for Evolution and no one else in connection with the Merger Offer and will not be responsible to anyone other than Evolution for providing the protections afforded to clients of Altium Capital, or for providing advice in relation to the Merger Offer or the New Evolution Shares. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Evgen Pharma (EVG)
UK 100

Latest directors dealings